1. Home
  2. VEEV vs BNTX Comparison

VEEV vs BNTX Comparison

Compare VEEV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEV
  • BNTX
  • Stock Information
  • Founded
  • VEEV 2007
  • BNTX 2008
  • Country
  • VEEV United States
  • BNTX Germany
  • Employees
  • VEEV N/A
  • BNTX N/A
  • Industry
  • VEEV Computer Software: Prepackaged Software
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VEEV Technology
  • BNTX Health Care
  • Exchange
  • VEEV Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • VEEV 37.4B
  • BNTX 28.3B
  • IPO Year
  • VEEV 2013
  • BNTX 2019
  • Fundamental
  • Price
  • VEEV $235.19
  • BNTX $120.10
  • Analyst Decision
  • VEEV Buy
  • BNTX Strong Buy
  • Analyst Count
  • VEEV 27
  • BNTX 16
  • Target Price
  • VEEV $253.15
  • BNTX $145.28
  • AVG Volume (30 Days)
  • VEEV 1.1M
  • BNTX 788.9K
  • Earning Date
  • VEEV 02-27-2025
  • BNTX 03-19-2025
  • Dividend Yield
  • VEEV N/A
  • BNTX N/A
  • EPS Growth
  • VEEV 16.44
  • BNTX N/A
  • EPS
  • VEEV 4.05
  • BNTX N/A
  • Revenue
  • VEEV $2,656,351,000.00
  • BNTX $3,390,698,192.00
  • Revenue This Year
  • VEEV $17.99
  • BNTX N/A
  • Revenue Next Year
  • VEEV $12.15
  • BNTX N/A
  • P/E Ratio
  • VEEV $57.65
  • BNTX N/A
  • Revenue Growth
  • VEEV 15.67
  • BNTX N/A
  • 52 Week Low
  • VEEV $170.25
  • BNTX $76.53
  • 52 Week High
  • VEEV $258.93
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • VEEV 61.47
  • BNTX 54.19
  • Support Level
  • VEEV $220.94
  • BNTX $117.49
  • Resistance Level
  • VEEV $239.64
  • BNTX $124.98
  • Average True Range (ATR)
  • VEEV 6.28
  • BNTX 4.81
  • MACD
  • VEEV 1.75
  • BNTX 0.34
  • Stochastic Oscillator
  • VEEV 78.24
  • BNTX 66.07

About VEEV Veeva Systems Inc.

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: